Hydromorphone Hydrochloride Dosage
Links shared publicly online about this topic
Lannett Receives FDA Approvals For Hydromorphone Hydrochloride Tablets USP, 2 Mg, 4 Mg And 8 Mg Strengths
medicalnewstoday.com — “Lannett Company, Inc. (NYSE AMEX: LCI) announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone ” View full resource at medicalnewstoday.com
Most Recently Shared on December 13, 2009 at 5:17 pm By:
MNT Pain News Pain Management and Health News
Lannett Receives FDA Approvals For Hydromorphone Hydrochloride Tablets USP, 2 Mg, 4 Mg And 8 Mg Strengths: Lannett ... http://bit.ly/8z1G3e
Akorn, Inc. Announces FDA Approval For Hydromorphone Hydrochloride Injection 10mg/ml In 1ml, 5ml And 50ml Doses
medicalnewstoday.com — “Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application” View full resource at medicalnewstoday.com
Most Recently Shared on April 18, 2010 at 12:05 pm By:
MNT Pharma News Health News and Pharma
Akorn, Inc. Announces FDA Approval For Hydromorphone Hydrochloride Injection 10mg/ml In 1ml, 5ml And 50ml Doses http://mnt.to/3Bnx
Bulletin
ashp.org — “Bulletin” View full resource at ashp.org
Most Recently Shared on December 22, 2011 at 6:58 am By:
HospiScript Services Health Organization
December 21st Release- Hydromorphone Hydrochloride Low Potency Injection Shortage http://t.co/flrcFNeg
Medical News: Morphine Combo Pain Drug Recalled - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “All dosage forms of the opioid painkiller combination product Embeda (morphine sulfate and naltrexone hydrochloride) have been recalled -- and will probably remain off the market for many months, it” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2011 at 6:00 pm By:
Physician Assistants Health News Feed
Morphine Combo Pain Drug Recalled - http://www.medpagetoday.com/ProductAlert/Prescriptions/25344
Watson files generic Exalgo ANDA, confirms patent challenge from Mallinckrodt
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. -- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.” View full resource at news-medical.net
Most Recently Shared on December 15, 2010 at 12:09 pm By:
Medicare News: Watson files generic Exalgo ANDA, confirms patent challenge from Mallinckrodt: Watson Pharmaceuti... http://bit.ly/f0gFg0
Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment... -- RIDGEFIELD, Conn. and INDIANAPOLIS, March 7, 2012 /PRNewswire/ --
prnewswire.com — “Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies. JENTADUETO, available in three dosage strengths, further expands treatment options for people living with diabetes.” View full resource at prnewswire.com
Most Recently Shared on March 7, 2012 at 5:13 pm By:
Scott Strumello Patient Expert
Boehringer Ingelheim & Lilly's new oral type 2 diabetes treatmt, Jentadueto™, now avail in US pharmacies http://t.co/gYbPMVrL via PRNewswire
FDA approves APP Pharmaceuticals' Idarubicin HCI injection
news-medical.net — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.” View full resource at news-medical.net
Most Recently Shared on August 10, 2009 at 2:05 pm By:
News-Medical.Net Health News and Oncology
Oncology News: FDA approves APP Pharmaceuticals' Idarubicin HCI injection: APP Pharmaceuticals, In.. http://bit.ly/a1e52
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Pain News
The latest pain and anesthetics news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Pharma News
The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.
-
HospiScript Services
Beyond Prescription Benefits Management, HospiScript partners with hospices to provide reduced drug costs, expert clinical support & educational opportunities.
Advertisement
